Upload Avatar (500 x 500)
Guohua Yang
ghyang@whu.edu.cn
Chinese, English
Hubei
Wuhan University
Basic Medical Sciences
  • 1992-1995: Associate Degree in Biology from Hubei Engineering College (formerly Xiaogan Teachers College)
  • 2001-2006: Master and PhD in Genetics from Wuhan University
  • 2011-present: Associate Professor at Wuhan University School of Basic Medical Sciences
  • 2014-2015: Visiting Scholar at Cleveland Medical Center, USA
  • 2006-2010: Lecturer at Wuhan University School of Basic Medical Sciences
  • 2010-2011: Deputy Director at Suizhou City Health Bureau, Hubei Province
  • 1995-1999: Biology Teacher at Wuhan Iron and Steel Ninth Middle School
  • 2006: Outstanding Young (Student) at Wuhan University
  • 2009: Excellent Guide Teacher for Wuhan University Students' Summer Social Practice
  • 2014: Second Prize at the 'Chunhui Cup' Chinese Overseas Innovation and Entrepreneurship Competition, New York Area
  • 2017: Most Potential Award at the 'Huachuang Cup' Innovation and Entrepreneurship Competition, Biomedical Field
  • 2019: Outstanding Party Worker at Wuhan University School of Basic Medical Sciences
  • 2021: Outstanding Class Tutor at Wuhan University School of Basic Medical Sciences
  • 2021: Wuhan University Teaching Achievement Award (Professional Theory Class Category)
  • 2021 and 2022: First Prize at Wuhan University in the 'Internet+' College Students Innovation and Entrepreneurship Competition, Silver Prize in Hubei Province
  • 2023: 'Gold Award' at Wuhan University Staff Innovation and Entrepreneurship Competition
  • 2023: 'Top Ten Entrepreneurs of Hubei Province' at the Sixth Hubei Provincial Education, Science, Culture, Health, and Sports System Staff Entrepreneurship and Innovation Finals
Functional research on genetic mutations in genetic diseases
Research on new methods of genetic diagnosis
Molecular mechanisms and drug discovery in liver cancer
  • Truncated FRMD7 Proteins in Congenital Nystagmus: Novel Frameshift Mutations and Proteasomal Pathway Implications, Guohua Yang et al., 2024
  • Autophagy inhibition mediated by trillin promotes apoptosis in hepatocellular carcinoma cells via activation of mTOR/STAT3 signaling, Guohua Yang et al., 2023
  • Double-network cellulose-based hybrid hydrogels with favourable biocompatibility and antibacterial activity for wound healing, Guohua Yang et al., 2023
  • Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma, Guohua Yang et al., 2022
  • DJ-1/FGFR-1 Signaling Pathway Contributes to Sorafenib Resistance in Hepatocellular Carcinoma, Guohua Yang et al., 2022
  • C1R, CL2, and TNFRSF1A Genes in Coronavirus Disease-COVID-19 Pathway Serve as Novel Molecular Biomarkers of GBM Prognosis and Immune Infiltration, Guohua Yang et al., 2022
  • Berberine exerts its antineoplastic effects by reversing the Warburg effect via downregulation of the Akt/mTOR/GLUT1 signaling pathway, Guohua Yang et al., 2021
  • Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine, Guohua Yang et al., 2021
  • A novel TSC1 frameshift mutation c.1550_1551del causes tuberous sclerosis complex by aberrant splicing and nonsense-mediated mRNA degradation (NMD) simultaneously in a Chinese family, Guohua Yang et al., 2020
  • Trillin prevents proliferation and induces apoptosis through inhibiting STAT3 nuclear translocation in hepatoma carcinoma cells, Guohua Yang et al., 2020
  • Identification and Interaction Analysis of Significant Genes and MicroRNAs in Pterygium, Guohua Yang et al., 2019
Genetic Diseases Gene Mutations Functional Research Genetic Diagnosis New Methods Liver Cancer Molecular Mechanisms Drug Discovery Biomedical Research Clinical Applications

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.